Archivo del sitio

Changing Faces: Stimulating the Brain Morphs People’s Faces Before Patient’s Eyes


The patient sits on the bed, his head wrapped in thick gauze bandages. He looks his doctor in the eye and says, “You just turned into somebody else… You almost look like somebody I’ve seen before, but somebody different. That

Tagged with: , , , , , , , , , , , , ,
Publicado en #gabrielcatalano, healthland.time.com

Aspirin, a Wonder Drug? Studies Show It May Prevent Cancer


Taken together, the findings are the first to show the benefits of aspirin in lowering cancer risk in short periods of time. Earlier studies had demonstrated reduced risk after about 8, 10 or as long as 20 years.

“These findings add to the case for use of aspirin to prevent cancer, particularly if people are at increased risk,” lead researcher Dr. Peter M. Rothwell, a professor of neurology at the University of Oxford, told Reuters.

The benefits of the low-cost therapy have to be balanced with its risks, however, which include gastrointestinal bleeding. Over time, said Rothwell, the risk of such bleeding appeared to wane, but additional studies need to be done to confirm that the prevention of cancer outweighs any potential complications that might arise from aspirin’s effect on the stomach.

That type of evidence is what some experts are still waiting for. “I think he’s on to something. I just want to be cautious, and I don’t want to exaggerate,” Dr. Otis W. Brawley, chief medical officer and executive vice president of the American Cancer Society, told the New York Times. “I’m not ready to say that everybody ought to take a baby aspirin a day to prevent cancer.”

Tagged with: , , , , , , ,
Publicado en healthland.time.com

Smoking May Lead to Faster Cognitive Decline in Men


Women, on the other hand, did not show any differences in cognitive scores over the same 10-year period. “The result among women was not particularly expected,” Sabia wrote in an email responding to questions about the study. But she says, it might easily be explained by the fact that there were fewer women in the study (2,137) than men (5,099), or because female smokers tended to smoke less than the men.

As far as the male smokers were concerned, the drop in cognitive functions, which included their scores on tests of memory, vocabulary, reasoning, verbal fluency and other executive skills, confirmed earlier studies that showed similar declines among those who lit up. But Sabia’s study is the first to find the effect in smokers as young as middle age. That suggests that tobacco can have an influence even on relatively young brains, and that its impact isn’t primarily due to the weaker neural networks of an already aging brain.

PHOTOS: Cigarette Warnings Around the World

But there was good news in the findings as well, especially for those who quit smoking. Men who had kicked the habit more than 10 years before the study began actually had better cognitive scores than men who had never smoked. Sabia credits this effect to the fact that people who quit smoking tend to become healthier overall, and may have adopted other lifestyle or diet changes that promoted better mental health.

That’s certainly encouraging, but Sabia cautions that the association between smoking and cognitive decline needs to be studied further. Because smokers tend to drop out of long-term studies of cognitive function due to disease, it’s possible that previous studies on the subject have underestimated the effect of lighting up on the brain. Sabia’s study is the first to use a statistical model to make up for this potential bias, but additional studies will need to confirm the relationship. If the research bears out, perhaps future public health messages about smoking will include warnings about cognitive harms as well as damage to the heart and lungs.

Tagged with: , , , , , , ,
Publicado en healthland.time.com

FDA Approves New Suppliers to Ease Cancer Drug Shortages


“We have made real progress … We believe that (suppliers) will be able to meet the demands of patients in the U.S. market” for the two drugs indefinitely, FDA Dr. Commissioner Margaret A. Hamburg told The Associated Press in an exclusive interview. “It’s a huge relief for us.”

The FDA increasingly has been able to prevent drug shortages, mainly due to a sixfold increase in manufacturers voluntarily notifying the FDA when they anticipate shortages, Hamburg said.

Thanks to such notice, the agency prevented 195 drug shortages in 2011, mostly late in the year after President Obama issued an executive order giving FDA additional powers to address the shortages. Between that order on Oct. 31 and this week, the agency has prevented a total of 114 drug shortages.

Hamburg said that when FDA’s much-expanded drug shortages team is notified about impending shortages and contacts other manufacturers, those companies have been “very responsive” as FDA worked with them on finding ways to boost production.

In the latest case, the FDA said it has temporarily allowed importation of an alternative to Doxil called Lipodox, made by Sun Pharma Global FZE. The Indian drugmaker is already known to the agency, and its factory and the production line for Lipodox have been inspected.

Tagged with: , , , , , , ,
Publicado en ***POST DESTACADO***, ***RECOMENDADO***, healthland.time.com

Whither Qnexa? A Brief History of Diet Pills and the FDA


To address those worries, Qnexa’s maker, Vivus Inc., had suggested approval of drug only for use in men and in women of non-childbearing age. That type of labeling work-around didn’t satisfy the FDA, however, and the agency asked the company to figure out a way to prevent pregnant women from using it.

Qnexa is not the first, nor will it be the last weight-loss pill to seek approval from the FDA. The market is ripe for a new drug to help Americans lose weight: “We really go from Weight Watchers to bariatric surgery when it comes to treatment options,” said Joseph Nadglowski, president of the Obesity Action Coalition, a patient advocacy group in Tampa, Fla., in an interview with Bloomberg. “For many, that’s a pretty big gap.”

But the FDA has a spotty history with diet drugs and an ever-rising bar for new weight-loss remedies. Following is a brief history of the diet drug industry’s successes, failures and near misses.

Amphetamines
The original diet drugs date back to the 1950s. Amphetamines worked simply by boosting metabolism all around, driving the body to burn more calories faster. The problem — as with any energy system pushed to its limits — was that cells aren’t made to burn, burn, burn. They eventually burn out, leading to heart problems, chest pains, palpitations, insomnia and other health issues.

Amphetamines, which boost energy and mood, are also addictive, since they tap into the brain’s reward system. After their potential for misuse emerged, U.S. and European officials banned most amphetamine-based medications, but the drug is still available, often hidden in South American diet remedies.

Fen-phen and Redux
A new combination of the existing appetite-suppressing drugs fenfluramine and phentermine, fen-phen was all the rage in the mid-1990s, leading to weight loss in hundreds of thousands of Americans. In 1996, after much media attention, the FDA approved a related drug, dexfenfluramine, as Redux, which did the same thing as fen-phen but with fewer side effects. Yet the side effects were still severe: in the summer of 1997, the FDA revealed that 82 patients had developed defects in their heart valves while on fen-phen, and that seven patients had come down with the same condition on Redux. Other patients developed pulmonary hypertension, a sometimes fatal lung condition, and a JAMA study confirmed earlier reports that both fen-phen and Redux caused brain damage in lab animals. After millions of prescriptions written, in 1997 both fenfluramine and Redux were pulled from the market.

Sibutramine (Meridia)
Since amphetamines carried too many risks of addiction and other side effects, researchers began focusing on ways to trick the brain into wanting less food. Sibutramine, approved in 1997, worked on brain chemicals that affect appetite: by blocking the reuptake of neurotransmitters such as norepinephrine and serotonin, the drug could suppress the desire to eat and convince the body that it was full, helping dieters lose 5% to 10% of their body weight in a few months. After studies showed users were at higher risk of developing heart problems and stroke, however, the medication was withdrawn from the market in 2010.

Lorcaserin (Lorqess)
Like sibutramine, lorcaserin focused on altering brain chemicals, specifically serotonin, to convince the body it was full. But an FDA panel recommended in 2010 against approving the drug because of studies in which female rats taking the drug developed a disturbing number of mammary tumors. The panel also asked Lorqess’s maker, Arena, to conduct additional tests on the drug’s effect on users with diabetes and heart disease, conditions that commonly affect those who are overweight.

Contrave

Tagged with: , , , , , , ,
Publicado en healthland.time.com
10:00 am to 05:00 pm | Mon-Fri
+5411 4954.0022 / +54 911 6259.7231
My about.me
Gabriel Catalano

Gabriel Catalano

Gabriel Catalano

diciembre 2014
L M X J V S D
« nov    
1234567
891011121314
15161718192021
22232425262728
293031  

Enter your email address to follow this blog and receive notifications of new posts by email.

Únete a otros 5.948 seguidores

Comunidad
Cruces, Sol y La Imaginación

Cuando la imaginación y la creatividad suman infinito

MarketingActivo

el mundo del marketing se activa para ti

tranquicomix

fanzine bejarano de historietas hecho en los 80

A Stairway To Fashion

contact: ralucastoica23@gmail.com

Vinod833's Blog

This WordPress.com site is the bee's knees

Apasionada de las Redes Sociales

Compartir conocimientos 2.0 y Marketing Online

Zona de Promesas

Blog de Tecnología en Español - Internet - Redes Sociales - Entrepreneurship - Innovación

Top Master | Blog

LOS PROGRAMAS DE MBA Y POSTGRADO MAS INFLUYENTES DE TODO EL MUNDO

La realidad alterna

Diario de sueños, cuentos, poesías y una novela en proceso

TechCrunch

Startup and Technology News

Unencumbered by Facts

Taking unsubstantiation to new levels

Carlos Cordero

Blog de tecnología

PsicoEmocions Blog

Un Pont entre la Psique i les Emocions

TEA PTLS NACHO

AUTISMO.TEA..PTLS

Comunicación & Marketing

De Lilian Lanzieri

Xtratexia

Dirección estratégica para la vida

Silvia Altamirano

An editorial designer that writes

StellarHIRE Partners

Founding Partner, StellarHire Partners - Executive Search Consultants. Recent engagements include Eloqua, SFDC, Tibco and Veeam.

ivanbrunpr's Blog

4 out of 5 dentists recommend this WordPress.com site

Matt on Not-WordPress

Stuff and things.

BLOGTEC

Noticias de Tecnologia.

Talento en Expansión

Tendencias y Mejores Prácticas en la Gestión de Personas de la Empresa 2.0

Two Leaves Tea SPAIN

Great Organic Tea! ✫✫✫✫✫ Te Organico en Piramides

Escuela de Dinero

El mejor Sitio en Español sobre lo básico para entender el Dinero y sus matemáticas relacionadas.

Intentando dejar huella...

...en cada uno de los visitantes

Ideas Para la Clase.com

Portafolio de experiencias en la clase de español para Middle School.

littlegreybox

Travel & Lifestyle Blog

déborah rueda

Un sitio más pero diferente sobre marketing on line

No solo los 80's

La mejor música de la historia

Molly Balloon's Blog

Identity + Dressing + Colour

El OJO PUBLICO. / Глаз общественности

Ver para contar & contar para ver. / Чтобы рассказать

Think Creative Idea

Marketing, publicidad, web y negocios

Social Media y más

Social Media, Redes Sociales, Marketing, SEO

The Coaching Alliance

El camino hacia el éxito

Luces y sombras de las marcas

Social Media, Marketing y Comunicación

CNNEspañol.com

Ultimas Noticias de Estados Unidos, Latinoamérica y el Mundo, Opinión y Videos

Javier GM Photography - México y más.

“Un fotógrafo tiene que ser auténtico y en su obra, debe expresar emociones, provocar reacciones y despertar pasiones.” ~ Javier García-Moreno E.

Natalia Gómez del Pozuelo

Experta en comunicación y oratoria

aloyn

Alimentación, ocio y negocios, ALOYN, es un Grupo dirigido a Directivos y Propietarios de empresas, interesados en el mundo de la industria de alimentación y bebidas. Tanto por la parte de la industria productora como por la parte de la industria consumidora y/o distribuidora (Distribución Comercial, Horeca, Vending, Venta Directa, etc). También nos interesan las actividades ligadas al agroturismo y el enoturismo como magníficas actividades de promoción y difusión de la cultura gastronómica.

Blog de Jack Moreno

Un blog de Joaquín Moreno sobre recursos, literatura y ciencia ficción

Mashamour

Ensalada de Manjares

Infographic List

For those who love Infographics - www.infographiclist.com

Seguir

Recibe cada nueva publicación en tu buzón de correo electrónico.

Únete a otros 5.948 seguidores